ARCHIVES

In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb

This article is from The Cancer Letter archive.

Vol. 21 No. 28 | July 14, 1995

Download PDF Visit The Full Archive

Related Articles

Provenge Met Criteria For Approval, Sponsor Says

May 1, 2009

DCT Board Sends Message On Cutting Grants to Extend Paylines, Then Tries To Take It Back

March 2, 1984

In Brief: Cancer Control Working New Review Guidelines: President Asks Congress For Cigarette Regulation

August 15, 1975

Viral Oncology Not Losing $5 Mil. This Year – But Watch Out for ‘79

January 6, 1978

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

October 17, 2014

House Reprogramming Of NCI Funds Analyzed; Community Programs Would Be Hurt

July 13, 1979